UBS Group Issues Pessimistic Forecast for CVS Health (NYSE:CVS) Stock Price

CVS Health (NYSE:CVS) had its target price decreased by UBS Group from $62.00 to $59.00 in a research note issued to investors on Tuesday. The firm presently has a “neutral” rating on the pharmacy operator’s stock. UBS Group’s target price points to a potential upside of 7.25% from the stock’s current price.

Several other research firms have also recently weighed in on CVS. Wells Fargo & Company upgraded CVS Health from an “equal weight” rating to an “overweight” rating and increased their price objective for the stock from $60.00 to $66.00 in a report on Monday, November 18th. StockNews.com cut CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. Royal Bank of Canada lowered their target price on CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research note on Friday, November 15th. Piper Sandler lowered their target price on CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a research note on Monday, November 25th. Finally, Edward Jones upgraded CVS Health from a “hold” rating to a “buy” rating in a research note on Thursday, January 30th. One analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $67.94.

CVS Health Trading Up 1.3 %

NYSE CVS traded up $0.72 on Tuesday, hitting $55.01. The company’s stock had a trading volume of 12,637,253 shares, compared to its average volume of 12,420,470. CVS Health has a 52-week low of $43.56 and a 52-week high of $80.75. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The company’s 50-day simple moving average is $50.69 and its 200 day simple moving average is $55.95. The firm has a market cap of $69.23 billion, a P/E ratio of 13.96, a PEG ratio of 0.60 and a beta of 0.61.

Institutional Trading of CVS Health

Several large investors have recently modified their holdings of CVS. AMF Tjanstepension AB lifted its position in shares of CVS Health by 124.1% in the third quarter. AMF Tjanstepension AB now owns 61,744 shares of the pharmacy operator’s stock valued at $3,882,000 after acquiring an additional 34,198 shares in the last quarter. Exchange Traded Concepts LLC increased its stake in CVS Health by 61.9% during the third quarter. Exchange Traded Concepts LLC now owns 14,853 shares of the pharmacy operator’s stock worth $934,000 after acquiring an additional 5,679 shares during the last quarter. Sound Income Strategies LLC increased its stake in CVS Health by 7.2% during the third quarter. Sound Income Strategies LLC now owns 2,397 shares of the pharmacy operator’s stock worth $151,000 after acquiring an additional 162 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. grew its stake in shares of CVS Health by 32.5% during the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 7,805 shares of the pharmacy operator’s stock valued at $491,000 after buying an additional 1,914 shares during the last quarter. Finally, Procyon Advisors LLC bought a new position in shares of CVS Health during the third quarter valued at approximately $202,000. Institutional investors own 80.66% of the company’s stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.